Impact BioMedical Inc. – AMEX:IBO

Impact BioMedical stock price today

$0.568
-0.87
-60.54%

Impact BioMedical stock price monthly change

-99.63%
month

Impact BioMedical stock price quarterly change

-99.63%
quarter

Impact BioMedical stock price yearly change

-99.63%
year

Impact BioMedical key metrics

Market Cap
 16.33M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Impact BioMedical stock price history

Impact BioMedical stock forecast

Impact BioMedical financial statements

Impact BioMedical alternative data

Impact BioMedical
Employees

Impact BioMedical Inc. (AMEX:IBO): Employee count
Dec 2024 1

Impact BioMedical other data

Impact BioMedical
Insider Trading

Impact BioMedical Inc. (AMEX:IBO): Insider trades (number of shares)
Period Buy Sel
Sep 2024 58800 0
Nov 2024 1550 5700
Dec 2024 500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HEUSZEL FRANK D director, officer.. Common Stock 500 $2.26 $1,129
Purchase
HEUSZEL FRANK D director, officer.. Common Stock 500 $2.61 $1,305
Purchase
HEUSZEL FRANK D director, officer.. Common Stock 500 $2.59 $1,295
Purchase
HEUSZEL FRANK D director, officer.. Common Stock 550 $2.63 $1,444
Sale
DSS, INC. 10 percent owner
 Common Stock 5,000 $3.02 $15,085
Sale
DSS, INC. 10 percent owner
 Common Stock 200 $2.8 $560
Sale
DSS, INC. 10 percent owner
 Common Stock 500 $2.76 $1,379
Purchase
DSS, INC. 10 percent owner
 Common Stock 1,000 $2.33 $2,330
Purchase
DSS, INC. 10 percent owner
 Common Stock 7,800 $2.4 $18,720
Purchase
DSS, INC. 10 percent owner
 Common Stock 50,000 $2.69 $134,500
IBO insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Impact BioMedical stock today?

    One share of Impact BioMedical stock can currently be purchased for approximately $0.57.

  • When is Impact BioMedical's next earnings date?

    Unfortunately, Impact BioMedical's (IBO) next earnings date is currently unknown.

  • Does Impact BioMedical pay dividends?

    No, Impact BioMedical does not pay dividends.

  • How much money does Impact BioMedical make?

    Impact BioMedical has a market capitalization of 16.33M.

  • What is Impact BioMedical's stock symbol?

    Impact BioMedical Inc. is traded on the AMEX under the ticker symbol "IBO".

  • What is Impact BioMedical's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Impact BioMedical?

    Shares of Impact BioMedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Impact BioMedical have?

    As Dec 2024, Impact BioMedical employs 1 workers.

  • What is Impact BioMedical's official website?

    The official website for Impact BioMedical is impactbiomedinc.com.

  • Where are Impact BioMedical's headquarters?

    Impact BioMedical is headquartered at 1400 Broadfield Blvd., Houston, TX.

  • How can i contact Impact BioMedical?

    Impact BioMedical's mailing address is 1400 Broadfield Blvd., Houston, TX and company can be reached via phone at +58 53253610.

Impact BioMedical company profile:

Impact BioMedical Inc.

impactbiomedinc.com
Exchange:

AMEX

Full time employees:

1

Industry:

Biotechnology

Sector:

Healthcare

Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.

+58 53253610
1400 Broadfield Blvd.
Houston, TX 77084

CIK: 0001834105
:
: